Physician
Pediatric Hematology & Oncology
Dr. Richard P. Kadota, MD
|
|
Give Review
Doctor Richard P. Kadota, MD is an expert in the field of Pediatric Hematology & Oncology. He went to Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19/29 in Research/PrimaryCare. Richard P. Kadota, MD is a published doctor and has 34 publications published. The lastest was: 'Perspectives on investigational chemotherapy and biologic therapy for childhood brain tumors.'
Publications
- Phase I study of tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for children with recurrent brain tumors: a Pediatric Blood and Marrow...
- Dose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent medulloblastoma or germinoma.
- A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric...
- Hepatoblastoma characterized by trisomy 20 and double minutes.
- Bone marrow transplantation for diseases of childhood.
- A dysmorphic child with myelodysplasia characterized by a duplication of 1q and multiple duplications of 3q.
- Multidisciplinary management of pediatric low-grade gliomas.
- Cardiopulmonary function in long-term survivors of childhood Hodgkin's lymphoma: a pilot study.
- A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia.
- Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study.
- A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas?
- Perspectives on investigational chemotherapy and biologic therapy for childhood brain tumors.
- Hyperfractionated irradiation and concurrent cisplatin in brain stem tumors: a Pediatric Oncology Group pilot study (9139).
- A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group Study.
- Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study.
- Cyclophosphamide for the treatment of progressive low-grade astrocytoma: a Pediatric Oncology Group phase II Study.
- There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncol...
- Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study.
- Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
- Biological modification strategies following marrow ablative, high-dose chemotherapy (HDCT) with autologous hematopoietic stem cell rescue (AHSCR) for pediatric brain ...
- Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium.
- Safety, efficacy, and pharmacokinetics of intravenous busulfan in children undergoing allogeneic hematopoietic stem cell transplantation.
- Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.
- The treatment of pediatric Philadelphia positive (Ph+) leukemias in the imatinib era.
- Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortiu...
- (123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trial.
- Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
- Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study.
- Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
- Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
- Temozolomide and radiation for aggressive pediatric central nervous system malignancies.
- Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia.
- Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237.
Schools
Northwestern Center Feinberg School of Medicine
Mayo Clinic Rochester
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
Mayo School of Graduate Medical Education -
Northwestern University Feinberg School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Sun H. Choo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hyunah E. Ahn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin E. Boatsman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald L. Durden, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Janet M. Yoon, MD
This Doctor is OpenDoctor Recommended.
|